View Alert
Originator: DHSC Supply Disruption Alert

Issue date: 28-Sep-2018 10:31:23

Action by recipients:
  • Acute Trusts
  • Learning Disabilities Trusts
  • Mental Health & Learning Disabilities
  • Community Trusts
  • Care Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices

Information to recipients:
  • Special Health Authorities
  • Other contacts
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Director of Public Health
  • Ofsted recipients
  • Social Care Providers (registered with CAS)
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups

Action category: Immediate Action

Title: EpiPen and EpiPen Junior - Supply disruption

Broadcast content: EpiPen and EpiPen Junior will be subject to limited availability for the remainder of 2018. Mylan are now out of stock of EpiPen Junior and interruptions in the supply are anticipated to continue for the coming months.

This alert provides details of actions to take around the prescribing, dispensing and administration of adrenaline auto-injectors.

Whilst the deadline for completing the actions is the end of this year, we expect organisations to begin following the actions immediately upon receipt of this alert.


Additional information: NHS Regional Offices: please cascade this alert to all primary care providers.

Alert reference: SDA/2018/001

Action underway deadline: 02-Oct-2018

Action complete deadline: 31-Dec-2018

Attachments:

Contact our helpdesk

Telephone: 020 3080 6747
Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency